Navigation Links
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Date:10/30/2007

PITTSBURGH, Oct. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel. As Global General Counsel, Mr. Haggerty will manage and oversee all legal issues and the provision of legal services, counsel and advice globally to all members of Mylan's senior management in their various roles across the Company.

Mr. Haggerty joins Mylan from Sanofi-Aventis U.S. Inc. where he served as Vice President, General Counsel, and Corporate Secretary. He joined Sanofi-Aventis after serving as Vice President and General Counsel for U.S. Commercial Operations at Aventis Pharmaceuticals, which was acquired by Sanofi in 2004. Prior to joining Aventis, Mr. Haggerty served as Head of the Product Liability Group at Warner-Lambert Company and, prior to that, he practiced for nine years at Shearman & Sterling LLP. Mr. Haggerty joins Mylan with 23 years of litigation, commercial, and regulatory experience, including 14 years in the pharmaceutical sector.

Mylan Vice Chairman and CEO Robert J. Coury said: "In Joe, Mylan is adding yet another highly qualified, top-caliber individual to bolster our broad and deep senior management team. His broad-based litigation experience, strong background in the pharmaceutical industry, and previous experience integrating two legal departments in a post-merger environment make him uniquely qualified for this position at Mylan."

Mr. Haggerty said: "I am thrilled to be joining Mylan at this exciting time in the Company's history. I look forward to joining the already impressive global management team and supporting them and their operations with my counsel as Mylan becomes one of the leading qual
'/>"/>

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 Memantine was initially developed ... marketed in Germany under the brand name Akatinol; it was ... as Ebixa and in the USA to Forest Labs as ... million in 2013. In the US, Forest reported Namenda sales ... expiry in Canada, Australia and the European region has increased ...
(Date:7/24/2014)... July 24, 2014 As the age ... to egg freezing as a way to ensure future ... otherwise decline with advancing reproductive age. Vitrification technology, a ... cutting edge medical technology that allows a woman to ... peak fertility years, which are then stored for future ...
(Date:7/24/2014)... with high-throughput data generated by breast cancer biologists ... computational method to determine how gene networks are ... as they respond to potential cancer therapy agents., ... each other in laboratory-grown cells is described in ... PLOS Computational Biology . , The method ...
(Date:7/24/2014)... In a recent report by CBS News, the district ... to criminal penalties associated with possession of small amounts of ... in Washington DC, giving it one of the most tolerant ... for possession of one ounce of marijuana or less with ... than an ounce of marijuana remain criminal offenses under the ...
(Date:7/24/2014)... from Penn Medicine shows that incisionless transcatheter aortic ... stay by 30 percent and has no impact ... conventional transfemoral TAVR, which requires an incision in ... the current issue of Circulation: Cardiovascular Interventions ... aortic valve without a traditional open-heart surgical approach. ...
Breaking Medicine News(10 mins):Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2
... treating severe and complex wounds in children that decreases the ... in Wound Repair and Regeneration shows that this technique has ... life-saving. ,“This wound therapy is usually delivered via ... wound base through a sponge sealed to the wound by ...
... Journal of Gastroenterology suggests that smoking may determine which ... who suffer from Crohn’s disease. Where the disease is ... surgical treatment. ,“In patients who smoke, Crohn’s ... intestine, rather than the colon,” says study author Dr. ...
... been recommended for medical conditions such as endometriosis, but ... for women who dislike menstruation or find it inconvenient. ... is it a reasonable lifestyle choice, asks Paula Derry, ... ,Birth control options that reduce or eliminate periods are ...
... can be highly addictive, warn two doctors in this week’s ... drugs is often forgotten, write Drs Chris Ford and Beth ... three patients with addictions to Nurofen plus (ibuprofen and codeine ... for its approved indications, but their use had escalated as ...
... bad news for older women who like their meat smoked or ... that post-menopausal women who consumed the most grilled, barbecued or smoked ... of breast cancer. Big meat-eaters who also skimped on fruit and ... scientists led by Dr. Susan E. Steck of the University of ...
... of America will hold a hearing on a neglected yet, crucial ... In America, one in three children do not have ... 25 million.,As for Medicaid, with the poorest children this is of ... its low reimbursement rates. , Lack of dental insurance, ...
Cached Medicine News:Health News:Should Menstrual Suppression Be a Lifestyle Choice? 2Health News:Barbeque Lovers Warned To Load On Fruits And Vegetables 2Health News:More Than a Toothache 2
(Date:7/24/2014)... July 24, 2014  Restore Health, a leading ... pharmaceuticals, announced that it is now offering pharmacogenetics ... each individual based upon their particular genetic makeup. ... the interaction between a patient,s genetics and their ... excited to provide this new service to healthcare ...
(Date:7/24/2014)... CITY, Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... First quarter overview: , Revenues of $47.5 ... , Diluted EPS of $0.21, up 50% over last ... Medical market revenues of $7.2 million, up 20% over ...
(Date:7/24/2014)... MOUNTAIN VIEW, Calif. , July 24, 2014 ... ), a leading provider of medication and supply ... hold a conference call Thursday, July 31, to ... What:  , Omnicell Second Quarter 2014 earnings ... 2014, 1:30 p.m. PTWho:  , Randall Lipps, chairman, ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... N.Y., Oct. 19 AccuVein LLC today announced a ... pharmaceutical and medical devices distribution company, providing the AccuVein ... to customers in Greece, Spain and Portugal. The AccuVein ... IV infusion and blood donation by projecting a pattern ...
... Pharmaceutical Research and Manufacturers of America (PhRMA) ... statement today regarding appropriate incentives for continued biotechnology ... healthcare providers, and elected leaders at the state ... responsible, abbreviated approval pathway for biosimilars that includes ...
Cached Medicine Technology:AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
... is an Auto Refractor/Keratometer with ... refinement. Electronic elevation, automatic alignment, ... accuracy and all the other ... Marco Automatic Refractors/Keratometer famous, make ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: